Spark Biomedical, a Dallas, TX-based well being tech firm which focuses on wearable neurostimulation know-how, raised $15M in Sequence A funding.
The spherical was led by WAVE Ventures with participation from Pathway to Cures.
The corporate intends to make use of the funds to speed up the event of its bioelectronic remedies, supporting the core areas of its enterprise: neurological well being, hemostasis, and ladies’s well being.
Led by CEO Daniel Powell, Spark Biomedical is a medical system firm for bioelectronic drugs that brings to market new wearable neurostimulation remedy choices in behavioral well being, girls’s well being, hemostasis, pediatrics, and persistent ache. It leverages experience to empower healthcare suppliers and researchers with instruments designed to deal with complicated care conditions which exceed the capabilities of current remedy choices.
FinSMEs
30/04/2025
